150 Research Primates' Diarrhea Yields Valuable Vaccine Data
An outbreak of diarrhea affecting over 150 research primates for two years has unexpectedly provided scientists with valuable data for developing a vaccine against Shigella bacteria.
An illness outbreak involving more than 150 non-human primates at a research center, characterized by diarrhea over a two-year period, has yielded significant data for scientists. The extended incident has offered an opportunity to better understand Shigella bacterial infections and advance vaccine development.
A study published in Science Translational Medicine details how researchers analyzed immunological data collected from the affected primates. The analysis identified new strategies for training the immune system to combat the Shigella bacteria. Scientists were able to pinpoint specific components of the bacteria that the immune system can most effectively target.
The research also precisely identified the sites on bacterial molecules where the most potent antibodies attached. This detailed understanding aids in comprehending the mechanisms of the immune response.
According to the authors, the study revealed unexpected features of the anti-Shigella antibody response in naturally infected non-human primates. It represents a step toward the rational design of Shigella vaccine candidates.